Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5478634 | 0.80 | GAA (0.41) | KDM4E | |
| SCHEMBL29013137 | 0.78 | GAA (0.39) | KDM4E | |
| SCHEMBL4417021 | 0.75 | PIM1 (0.42) | KDM4EPIM1 | |
| SCHEMBL13303583 | 0.75 | PIM1 (0.42) | KDM4EPIM1 | |
| SCHEMBL20061124 | 0.75 | PIM1 (0.42) | KDM4EPIM1 | |
| SCHEMBL20061161 | 0.74 | KDM4E (0.34) | KDM4EPIM1 | |
| SCHEMBL20061147 | 0.74 | KDM4E (0.34) | KDM4EPIM1 | |
| SCHEMBL25795988 | 0.73 | — | — | |
| SCHEMBL22647693 | 0.73 | PIM1 (0.41) | KDM4EPIM1 | |
| Hydrochloric Acid SCHEMBL6656735 | 0.70 | PIM1 (0.40) | KDM4EPIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1692149-B1 | METHOD FOR PRODUCING ORTHOMETALATED AND ORTHOSUBSTITUTED AROMATIC COMPOUNDS | SOLVIAS AG (CH) | 2009-07-22 | — | — | EP | disclosed |
| US-7435840-B2 | Method for producing orthometalated and orthosubstituted metallocenes | SOLVIAS AG (CH) | 2008-10-14 | — | — | US | disclosed |
| US-20070149796-A1 | Ortho-functionalized mono- and diphosphino- ferrocenes, bisindenylferrocenes and ruthenocenes and their borane complex intermediates; valuable ligands for metal complexes serving as catalysts for, e.g. enantioselective hydrogenations | SOLVIAS AG (CH) | 2007-06-28 | — | — | US | disclosed |
| EP-1692149-A2 | METHOD FOR PRODUCING ORTHOMETALATED AND ORTHOSUBSTITUTED AROMATIC COMPOUNDS | Solvias AG (CH) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005056566-A2 | METHOD FOR PRODUCING ORTHOMETALATED AND ORTHOSUBSTITUTED AROMATIC COMPOUNDS | SOLVIAS AG (CH) | 2005-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149796-A1 | Ortho-functionalized mono- and diphosphino- ferrocenes, bisindenylferrocenes and ruthenocenes and their borane complex intermediates; valuable ligands for metal complexes serving as catalysts for, e.g. enantioselective hydrogenations | BCL3, ORC3, BBC3 | KDM4E 3570/4885PIM1 2491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.